Our results demonstrated that SZ-685C suppressed the proliferation of ADR-resistant MCF-7/ADR and MCF-7/Akt breast cancer cells as well as the growth of MCF-7/ADR xenografts, suggesting a potentially promising approach to the treatment of ADR-resistant breast cancer. The gene discussed is AKT1; the disease is breast cancer.